Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Market outline PART 05: Market landscape • Market overview • Market size and forecast • Five forces analysis PART 06: Market segmentation by product • Global HA market by product type • Global five-injection cycle HA market • Global three-injection cycle HA market • Global single-injection cycle HA market PART 07: Market segmentation by application • Global HA market by application • Global HA market in the dermal fillers segment • Global HA market in the osteoarthritis segment • Global HA market in the ophthalmic surgery segment • Global HA market in the VUR segment PART 08: Geographical segmentation • Global HA market by geography • HA market in North America • HA market in Europe • HA market in APAC • HA market in ROW PART 09: Decision framework PART 10: Drivers and challenges • Market drivers • Market challenges PART 11: Market trends • Production of HA with cost-effective raw materials • Rising substitutes for HA PART 12: Vendor landscape • Competitive scenario • Key market vendors • Other prominent vendors PART 13: Key vendor analysis • ALLERGAN • Anika Therapeutics • Sanofi • SEIKAGAKU • Zimmer Biomet PART 14: Appendix • List of abbreviations List of Exhibits Exhibit 01: Synonyms of HA Exhibit 02: Synthesis of HA (process flow) Exhibit 03: Segmentation of global HA market Exhibit 04: Global HA market 2016 and 2021 ($ millions) Exhibit 05: Market forecast: Global HA market 2016-2021 Exhibit 06: Five forces analysis Exhibit 07: Global HA market by product type 2016 (% share of revenue) Exhibit 08: Global HA market by product type 2021 (% share of revenue) Exhibit 09: Global five-injection cycle HA market 2016 and 2021 ($ millions) Exhibit 10: Market forecast: Global five-injection cycle HA market 2016-2021 Exhibit 11: Global three-injection cycle HA market 2016 and 2021 ($ millions) Exhibit 12: Market forecast: Global three-injection cycle HA market 2016-2021 Exhibit 13: Global single-injection cycle HA market 2016 and 2021 ($ millions) Exhibit 14: Market forecast: Global single-injection cycle HA market 2016-2021 Exhibit 15: Global HA market by application 2016 (% share of revenue) Exhibit 16: Global HA market by application 2021 (% share of revenue) Exhibit 17: Global HA market in the dermal fillers segment 2016 and 2021 ($ millions) Exhibit 18: Market forecast: Global HA market in the dermal fillers segment 2016-2021 Exhibit 19: Global HA market in the osteoarthritis segment 2016 and 2021 ($ millions) Exhibit 20: Market forecast: Global HA market in the osteoarthritis segment 2016-2021 Exhibit 21: Global HA market in the ophthalmic surgery segment 2016 and 2021 ($ millions) Exhibit 22: Market forecast: Global HA market in the ophthalmic surgery segment 2016-2021 Exhibit 23: Global HA market in the VUR segment 2016 and 2021 ($ millions) Exhibit 24: Market forecast: Global HA market in the VUR segment 2016-2021 Exhibit 25: Global HA market by geography 2016 (% share of revenue) Exhibit 26: Global HA market by geography 2021 (% share of revenue) Exhibit 27: HA market in North America 2016 and 2021 ($ millions) Exhibit 28: Market forecast: HA market in North America 2016-2021 Exhibit 29: HA market in Europe 2016 and 2021 ($ millions) Exhibit 30: Market forecast: HA market in Europe 2016-2021 Exhibit 31: HA market in APAC 2016 and 2021 ($ millions) Exhibit 32: Market forecast: HA market in APAC 2016-2021 Exhibit 33: HA market in ROW 2016 and 2021 ($ millions) Exhibit 34: Market forecast: HA market in ROW 2016-2021 Exhibit 35: Population of age 65 years and above (% of total population) (2005-2016) Exhibit 36: Applications of HA in dermal fillers Exhibit 37: Side effects of HA Exhibit 38: Key market vendors Exhibit 39: ALLERGAN: Business segmentation by revenue 2016 (% share) Exhibit 40: Anika Therapeutics: Business segmentation by revenue 2016 (% share) Exhibit 41: Anika Therapeutics: Geographical segmentation by revenue 2016 (% share) Exhibit 42: Sanofi: Business segmentation by revenue 2016 (% share) Exhibit 43: Sanofi: Geographical segmentation by revenue 2016 (% share) Exhibit 44: SEIKAGAKU: Business segmentation by revenue 2016 (% share) Exhibit 45: SEIKAGAKU: Geographical segmentation by revenue 2016 (% share) Exhibit 46: Zimmer Biomet: Business segmentation by revenue 2016 (% share) Exhibit 47: Zimmer Biomet: Geographical segmentation by revenue 2016 (% share)

ALLERGAN, Anika Therapeutics, Sanofi, SEIKAGAKU, Zimmer Biomet, Contipro, Ferring, Fidia Farmaceutici, Galderma, Hyalogic, HYALTECH, Lifecore Biomedical, Maruha Nichiro, Meiji Holdings, Merz Pharma, Rayner, Shiseido, TRB CHEMEDICA INTERNATIONAL, and Valeant.